Navigation Links
The Polymicrobial Nature Of Diabetic Foot Infections

Foot infections are a major cause for hospitalization of patients with diabetes. Foot ulceration and infection are risks for subsequent amputation. Ischemia, neuropathy, and infection in patients with diabetes combine to produce tissue necrosis and ulcers//. Diabetic foot infections are generally polymicrobial in nature.

Early recognition of lesions and prompt initiation of appropriate antibiotic therapy, as well as aggressive surgical debridement of necrotic soft tissue and bone, and a modification of host factors (i.e., hyperglycemia, concomitant arterial insufficiency) are important for successful outcome.

A recent study, published in the May-June issue of Journal of Diabetes and its Complications, evaluated the bacteriology of diabetic foot ulcers at the Adan teaching hospital, Ministry of Health in Kuwait, Kuwait. The relative frequency of bacterial isolates cultured from community-acquired foot infections that were not exposed to antimicrobial agents for 30 days were studied. In addition, the bacterial comparative in vitro susceptibility to the commonly used antibacterial agents was assessed.

During the study, the infected wounds of 86 consecutive diabetic patients were cultured. The patients did not receive antimicrobial therapy 30 days prior to taking the cultures. The specimen was cultured using aerobic and anaerobic microbiological techniques. Isolates were tested for susceptibility to commonly used antimicrobial therapy. S. aureus and P. aeruginosa were found to be the most common causes of diabetic foot infections.

Anaerobic organisms, majority of them were bacteroids, are still a common cause for infection, although the prevalence is less. These wounds may require use of combined antimicrobial therapy for initial management. Among the gram-negative enteric bacilli, P. mirabilis was the most frequently seen, followed by Escherichia coli and Klebseilla. Imipenem, meropenem, and cefepime were th e most effective agents against gram-negative organisms. Vancomycin was the most effective against gram-positive organisms.

The authors suggest that while choosing an antimicrobial for the treatment of diabetic foot infections, one should consider the spectrum of causative organisms, their resistant patterns, efficacy, and safety. Awareness of the causative organisms in diabetic foot infections and their antimicrobial susceptibility pattern is essential for the institution of antimicrobial therapy.
'"/>




Related medicine news :

1. Reaction To ADHD Medication May Be Genetic By Nature
2. Risk Of Stroke May Be Genetic By Nature
3. Nature Cures The Best, Say WIC Clinic Clients
4. Nature’s fury leaves permanent scar
5. Nature’s Bounty ,Seaweed, Becomes A Blessing For Diabetes Patient
6. Morning Sickness - Natures Way Of Ensuring Healthy Diet In Pregnancy
7. Morning Sickness: Natures Warning Signal To Would –Be- Mom
8. Where Burnt Out Executives De-stress in Natures Lap
9. Nature Behind Most New Drugs
10. New Drug in Diabetic Neuropathy
11. Cinnamon May Help Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... The annual board election process has been in place since the RBMA was founded ... Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the ...
(Date:4/28/2017)... Texas (PRWEB) , ... April 28, 2017 , ... The ... plaque in recently to the labor and delivery team at Women’s Hospital at Renaissance ... mothers who give birth at the hospital and decide to donate. , “Women’s ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing ... aid doesn’t have the stigma it had when great-grandpa wore his hearing aids years ... in a NALA North American Speaker Series (NASS) segment. “He probably wore ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology: